MedPath

Therapeutic effect of thumbtack needle in the treatment of allergic rhinitis and its immune regulation of ILC-2 cells: a randomized controlled trial

Phase 1
Recruiting
Conditions
Allergic rhinitis
Registration Number
ITMCTR1900002391
Lead Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1 Meet the allergic rhinitis Chinese and western diagnostic criteria.
2 Aged 18 to 65 years, gender is not limited.
3 Sign the informed consent form and volunteer to participate in the study.
4 Participants can fill in the case report form and follow-up form by themselves.

Exclusion Criteria

1 Acute rhinitis (cold), vasomotor rhinitis, autonomic rhinitis, eosinophilic non-allergic rhinitis, allergic sinusitis.
2 Tape allergy history.
3 Local skin lesions such as burns, eczema, ulcers, frostbite ulceration.
4 During pregnancy and intent to pregnant women.
5 Due to intellectual or behavioral disorders, the test and investigators cannot be fully matched.
6 Participants who are lost to follow-up due to frequent changes in the working environment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.